Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Virtual Conference 2021 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#834 Nuclear Imaging in Intermediate Grade Neuroendocrine Tumors

Introduction: Early diagnosis and grading is essential to the treatment decision-making in neuroendocrine tumors. Conventionally, proliferation rate (Ki-67) level is used for the grading of NET. Ga-68 SMS-R PET/CT is the imaging method of choice for the detection of unknown primary neuroendocrine tumors. It is very sensitive in well-differentiated tumors (Ki-67 < 2%). Poorly and undifferentiated tumors having Ki-67 greater than 20% are primarily responsible for false negativity of Ga-68 SMS-R PET/CT. In those patients, FDG-PET is performed to localize the site of the primary tumor.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Abou Yehia Z, Haydar A, Haydar M, Mukherji D, Temraz S,

Keywords: neuroendocrine tumors, nuclear imaging, histopathology ,

#310 Relationship Between Dose and Molecular Response After Peptide Receptor Radionuclide Therapy (PRRNT) in Neuroendocrine Tumors: Preliminary Results

Introduction: PRRNT is an effective therapy option in well-differentiated neuroendocrine tumors. However, there exists no study showing the ability to predict response to PRRNT on a pretherapy Ga-68 SMS-R PET/CT.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Kulkarni H, Prasad V, Schuchardt C, Baum R,

Keywords: dose, molecular, response,

#242 Ga-68 SMS-R PET/CT in the Detection of Unknown Primary Neuroendocrine Tumor- Single Centre Result in 124 Patients

Introduction: Ga-68 Somatostatin-Receptor PET/CT (R-PET/CT) has been reported to be superior to In-111 octreoscan in the detection of unknown primary of neuroendocrine tumors (CUP-NET) (EJNMMI 2010 Jan;37(1):67-77)

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Prasad V, Hommann M, Settmacher U, Kaemmerer D, Hoersch D,

Keywords: CUP NET, Ga-68 SMS-R PET/CT,

#162 Different sites of rare metastases in neuroendocrine tumor patients detected by Ga-68 somatostatin receptor PET/CT

Introduction: The most common sites of metastases in neuroendocrine tumors are liver, lymph nodes, and bone.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Prasad V, Baum R,

Keywords: neuroendocrine tumors, rare sites of metastases, Ga-68 SMS-R PET/CT,

#159 Detection of cardiac metastases in patients with neuroendocrine tumors: comparison of Ga-68 DOTA-SMS-R PET/CT, cardiac MRI, CT scan and 2D echocardiography

Introduction: Neuroendocrine tumor metastases to the heart have been sparsely reported in literature. There is as of yet no detailed study on the best imaging method for the detection of this rare site of metastases.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Prasad V, Ali S, Secknus M, Lauer B, Hoersch D,

Keywords: neuroendocrine tumors, cardiac metastases, Ga-68 SMS-R PET/CT, echocardiography, MRI,

Abstract Submissions in 2022

Abstract submissions for 2022 will open in September 2021!

 

The 19th Annual ENETS Conference in 2022 will provide the principal platform for NET researchers around the world to present their latest findings. ENETS will select the best abstracts submitted in both clinical and basic science and present these in sessions within the framework of its scientific programme.

 

Participants of the ENETS Virtual Conference 2021 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

Membership matters

Multidisciplinary is our credo. We welcome all NET-related disciplines and professionals! Learn more about the benefits of becoming an ENETS member.